BARCELONA, Spain and DÜSSELDORF, Germany, July 24, 2026 -- Minoryx Therapeutics and Neuraxpharm Group, announce that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has...
Jeff Collins will participate on a panel titled "Funding Innovation, Cross-Border Investments and M&A Trends" at the US India BioPharma & Healthcare Summit in Cambridge, MA
News | 05. 14. 2009
